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Inserting Pharmacists in Primary Care 
Roles in an Ambulatory Care Setting
KEITH YOSHIZUKA, PHARMD, MBA, JD, FCSHP, KATHERINE KNAPP, PHD 
PATRICIA SHANE, PHD, MPH, DEBBIE LU, PHARMD, MPH
Rarely are health system administrators not concerned with finding adequate financial resources to provide quality care to the communities they serve. The Patient Protec­
tion and Affordable Care Act (PPACA) promises to bring more patients to hospital doors 
while, at the same time, reducing reimbursement for their hospitalization costs. The Center 
for Medicare and Medicaid Services (CMS) threatens reduced reimbursement for rehos­
pitalization of patients within 30 days for similar diagnoses. To further exacerbate these 
financial pressures, the lack of primary care physicians forces hospitals into competition 
for physician services they can ill afford. What can be done?
In this report, we suggest how pharmacy personnel may be used to alleviate some of 
the pressures currently impacting health system administrators. We look back to the 
role(s) of the hospital pharmacy and the hospital pharmacist historically and outline 
changes that have occurred and how these changes may be helpful to address several 
problem areas in the ambulatory care venue.
The American College of Clinical Pharmacy defines clinical pharmacy as “a health 
science discipline in which pharmacists provide patient care that optimizes medication 
therapy and promotes health, wellness, and disease prevention.”1 Clinical pharmacists 
assume responsibility and accountability for achieving therapeutic goals in all areas 
of pharmacy including critical care, anticoagulation, cardiology, geriatrics, immu­
nization, infectious disease, nephrology, neurology, pediatrics and oncology. They 
serve as consulting pharmacists for long-term care facilities to ensure patients are 
receiving optimal medication therapy. They manage patient therapy in direct patient 
care settings working under protocol for conditions such as diabetes, anticoagulation 
management, immunization, and oncology/chemotherapy management.
Hospital pharmacies were historically sites for procuring medications and managing 
medication orders. Clinical pharmacy in hospitals was spawned by the expansion 
of new and expensive medications and the need for monitoring medications with 
possible serious side effects and/or very high costs. The clinical pharmacist often 
needed to be at the bedside thereby moving pharmacy for the first time out of the 
(usually) basement-based pharmacy and onto the hospital’s service units. The presence 
of pharmacists “on the floors” has gradually led to integration of pharmacists into the 
hospital healthcare team. A significant benefit of this shift is the presence in California 
of a larger cohort of pharmacists with clinical skills who can be mobilized to fill new 
roles that require clinical expertise.
Hospitals Utilization of Clinical Pharmacists: We now see smaller units, including 
hospitals, building clinics that offer other out-of-hospital services for high risk patients 
in order to make financially and clinically feasible strategies for sustained, successful 
operation. The role of pharmacists in these expanded operations is one factor to be 
considered as these models are rolled out. For example, in 2009 Jack et al piloted an
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Clinical pharmacy in 
hospitals was spawned 
by the expansion of 
new and expensive 
medications and the 
need for monitoring 
medications with 
possible serious side 
effects and/or very 
high costs.
intervention at San Francisco General 
Hospital and Trauma Center to test 
the effects of a care transition program 
designed to minimize hospital utiliza­
tion after discharge. The intervention 
included a clinical pharmacist calling 
patients 2 to 4 days after discharge to 
reinforce the discharge plan and review 
medications. The authors found that 
participants in the intervention had 
a significantly lower rate of hospital 
utilization and hospital utilization 
cost savings that averaged $412 per 
discharge as compared with those 
receiving usual care.2 Kern Medical 
Center’s utilization of clinical pharma­
cists is another example of a community 
hospital tapping into existing healthcare 
resources to improve health outcome 
and reduce healthcare cost. Kern 
Medical Center is a 222-bed acute care 
teaching hospital owned by Kern County 
in Bakersfield, California. It has affili­
ations with UCLA and UCI Schools of 
Medicine and USC and UOP Schools of 
Pharmacy. Pharmacists at this medical 
center provide services including 
diabetes management, anticoagulation 
management, blood pressure manage­
ment, oncology services, and smoking 
cessation program. Overall, 32% of 
patients in the Medicine Clinic are seen 
by a clinical pharmacist. An evaluation 
of the KMC’s Pharmacy Diabetes Clinic 
indicated that the services provided by 
clinical pharmacists assisted patients in 
meeting clinical guideline for Ale, blood 
pressure, and cholesterol level goals.3
Changes in the Hospital 
Environment: The Emergence 
of Clinics
The historic successful co-existence of 
office-based physicians, medical groups 
and hospitals was based on the ability of 
each entity to succeed independently with 
relatively non-binding relationships with 
other entities. The emergence of health 
plans and changes in reimbursement 
structures forced hospitals to vertically 
integrate, adding services such as clinics
for patients with chronic illnesses in order 
to retain a patient base. The emergence of 
clinics to provide care for patients with 
common, chronic medical conditions 
like diabetes began, not surprisingly, in 
organizations like the Veterans Admin­
istration and Kaiser Permanente where 
the organization had an obligation to 
care for a defined population on a fixed 
budget. These organizations were also 
the first to place pharmacists in clinic 
settings alongside physicians and nurses 
to help patients maintain health and 
avoid complications. These efforts were 
successful and have become a permanent 
feature of the care package. In a recent 
publication by Hill et al, for example, the 
authors described the comprehensive 
ambulatory clinical pharmacy services 
that are available at Kaiser Permanente 
Colorado (KPCO).4 KPCO has approxi­
mately 530,000 members and 150 clinical 
pharmacists who provide clinical phar­
macy services. The primary roles of the 
clinical pharmacists in these settings were 
to assist providers in optimizing medica­
tion therapy to improve clinical outcomes 
while minimizing the total costs of care.2 
Clinical pharmacists at Kaiser Perma­
nente work in a wide variety of service 
areas including asthma/allergy, behav­
ioral health, gastroenterology, infectious 
disease, inpatient, nephrology, cardiology, 
diabetes/endocrinology, dementia care, 
and emerging area of continuing care.2,5 
A 2011 Report to the Surgeon General 
provided extensive documentation of the 
value produced by pharmacists working 
in clinic settings. Oncology is an area 
where pharmacists have started their 
services in the inpatient setting and tran­
sitioned into the ambulatory care setting. 
As oncology treatment migrated from 
hospitals to infusion centers and other 
ambulatory care settings, pharmacists 
were hired into these outpatient settings 
to prepare medications, dose, and manage 
symptoms related to chemotherapy.
Today there are over 1,600 pharmacists 
who are Board certified in oncology.7
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S afe ty  N et Clinics
One of the factors limiting the incor­
poration of clinical pharmacists into 
the multi-disciplinary care team in the 
clinic setting is the financial burden, as 
pharmacists are not reimbursed for their 
services by third party payers. Recog­
nizing the important role that clinical 
pharmacists play in patients’ health, 
particularly underserved populations 
with complex medical conditions, many 
colleges of pharmacy have developed 
partnerships with community medical 
clinics to enhance the pharmaceutical 
care in these populations. Examples of 
this include community partnerships 
between the University of Southern 
California School of Pharmacy and the 
Los Angeles County community clinics,2 
Touro University and San Francisco 
General Hospital and Trauma Center, 
LifeLong Medical Care, and Clinic Ole 
in Napa. The pharmacists in these clinics 
provide clinical services including, but 
not limited to, a review of the patients 
medication experience, updating 
medication allergies and adverse reac­
tions, reviewing medication history and 
current medication record for indication 
for use, product, dose, duration, and how 
the medication is actually being taken. 
Pharmacists also review active drug 
therapy problem lists and therapeutic 
treatment plans for appropriateness, 
effectiveness, safety, and medication 
adherence for vulnerable population in 
safety net clinics.
C o n s id e ra tio n s  fo r  P lac ing  
P h arm ac is ts  in A m b u la to ry  
C are (am  care ) C lin ics
Available evidence cited above suggests 
that when a hospital decides to initiate 
or expand ambulatory care clinics as 
part of its service package, it is logical 
to consider a role for pharmacists. The 
principal issues to be considered when 
moving in this direction are 1) financial 
considerations and 2) establishing a 
plan for introducing pharmacists into a 
clinic model.
Median 2012 annual salaries before 
benefits as reported by the Bureau of 
Labor Statistics (BLS) are: physicians 
($187,200), registered nurses ($65,470) 
and pharmacists ($116,670).8’9,10 The 
relatively high pharmacist salaries and 
reimbursement issues (discussed in 
other sections) have caused hospital 
administrators and others to demand 
financial justification for adding 
pharmacists to clinics. While there is 
abundant evidence of both financial and 
clinical value of clinical roles for phar­
macists in clinics; much of the evidence 
comes from governmental or managed 
care organizations. Different business 
models and circumstances often make 
this justification a required step prior 
to adding pharmacists. Their justifica­
tion is generally based on demonstrating 
reduced overall patient utilization of 
expensive services (hospital and emer­
gency department use) and savings 
on expensive medication use. Experi­
menting with pharmacist roles is often 
an initial step. Many organizations 
experiment with new roles for pharma­
cists by adding a pharmacy resident(s). 
The resident’s salary cost is less (approxi­
mately $46,000-$48,000 annual salary) 
and residency training is highly oriented 
to experimentation and data collection. 
Pharmacy residencies generally last 
one year—sufficient time to integrate 
into a service and observe the impact. 
There are many examples where data- 
driven, successful residencies result in 
converting the residency position to 
a staff position. (Residency training 
programs are described below).
Generally, adding pharmacists to clinics 
occurs in the setting of existing clinics 
run by physicians overseeing nurses 
who work directly with patients (case 
management). Pharmacists are often 
introduced into this traditional model 
by initially working as a consultant to 
the nurses for patients with complex 
medication regimens. Gradually, the 
pharmacist establishes an integrated
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role that is best described as a referral 
role where both physicians and nurses 
refer those cases where the pharmacist’s 
expertise in medication management is 
likely to improve patient outcomes.
Pharmacists have identified a niche 
in managing chronic diseases treated 
primarily with medication, diet, and 
exercise (such as hypertension, diabetes, 
and hypercholesterolemia); and 
managing anticoagulant drug therapy. 
Pharmacists have also played an impor­
tant role in oncology through managing 
chemotherapy, symptom management 
support, pain management, assessment 
of response and toxicities, and manage­
ment of nausea and vomiting through 
antiemetic therapy. This is contrasted 
with the roles of nurse practitioners 
and physician assistants who play major 
roles in urgent care clinics, physical 
assessment screenings, emergency 
departments, and working with ortho­
pedic surgeons.
A v a ila b ility  o f A p p ro p ria te ly  
Tra ined  Personnel: Can You 
Find th e  R ight People?
There are approximately 35,000 licensed 
pharmacists in California about 25% of 
whom practice in hospitals (<9,000).11,12 
The number of pharmacists already 
working in clinics is unknown but likely 
less than 3,000. California law requires 
that in order to work in a clinic setting, 
a pharmacist must have either success­
fully completed a pharmacy residency or 
have demonstrated clinical experience 
in direct patient care delivery. Many 
pharmacists who have worked in an 
acute care setting in California have this 
clinical experience through the protocols 
of the hospital in managing the dosing of 
various antibiotics, parenteral nutrition, 
and anticoagulation therapies.
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R esidency-tra ined  
Pharm acists and  
C ertifica tio n  in S pec ia lty  Areas
Nationally, there has been rapid growth 
in pharmacy residencies. Based upon 
2013 data, available through the Phar­
macy Online Residency Centralized 
Application System (PhORCAS), there 
were over 1,600 residency programs that 
collectively offered over 3,000 positions. 
Despite the expansion of pharmacy 
residencies there continues to be unmet 
need, as evidenced by the volume of 
individual PGY1 and PGY2 applications 
(n=5,808) received that year, Pharmacy 
residencies are defined as an organized, 
directed, postgraduate training program 
in a defined area of pharmacy practice.13 
The majority of pharmacy residencies are 
pursued immediately after graduation 
from pharmacy school and last one year. 
These residencies are identified as Post- 
Graduate Year 1 (PGY1) residencies.
The American Society of Health-System 
Pharmacists (ASHP) is the main accred­
iting body for accrediting health-system 
pharmacy residencies. Pharmacists who 
complete an ASHP-accredited PGY1 
residency or a residency with Candidate 
status with ASHP are eligible to take 
a Board of Pharmaceutical Specialties 
(BPS) examination in Pharmacotherapy 
that, if passed, identifies them as BPS- 
certified in Pharmacotherapy.14 The 
Board-certified designation is helpful 
to hospitals for internal credentialing, 
credibility and comfort with assigning 
clinical roles.
Specialty residencies—referred to as 
PGY2 programs—offer additional 
postgraduate training in areas such as 
ambulatory care, critical care, psychiatry, 
nutrition support, oncology and infec­
tious disease. Pharmacists who complete 
PGY2 residencies are eligible to take BPS 
examinations in specialty areas. Current 
areas of specialization include ambula­
tory care, nuclear pharmacy, nutrition 
support, oncology and psychiatric
Pharmacists in Primary Care
pharmacy. Pediatrics and critical 
care have recently been added as BPS 
specialties with certification examina­
tions to begin in Fall 2015.15 Passing the 
examination(s) qualifies the pharmacist 
as BPS-certified in a specialty area. The 
Board-certified specialty designation 
is again helpful to hospitals for creden- 
tialing, credibility and comfort with 
assigning clinical roles.
Residency programs can apply for 
accreditation through the American 
Society of Health-System Pharmacists 
(ASHP). Accreditation implies that the 
program has met ASHP standards for 
residency training. Continued accredi­
tation requires periodic re-application 
and site visits. A listing of ASHP- 
accredited programs is available on 
the ASHP website (http://accred.ashp. 
org / aps/pages/directory/residency- 
ProgramSearch.aspx). Many residency 
programs do not apply for ASHP accred­
itation for a variety of reasons. There 
is no reliable listing of non-accredited 
programs but it is estimated that ASHP- 
accredited programs account for about 
two-thirds of residencies.
Hospitals wishing to explore or start 
residency programs can find help. ASHP 
ofFers specific information about starting 
residency programs.16 Many hospitals 
will find willing partners in schools or 
colleges of pharmacy. Pharmacy schools 
make good partners for the research 
projects that residents are required to 
complete and pharmacy schools prefer 
to have their students train in hospitals 
where residency training is concurrent. 
Professional meetings of ASHP, CSHP 
and the American College of Clinical 
Pharmacists (ACCP) almost always 
include programming about starting and 
managing residencies.
Whether PGY1 or PGY2, residents are 
required to complete a research project. 
These projects often present opportu­
nities for hospitals to assess internal
processes regarding the use of medi­
cations and to experiment with new 
services, processes and procedures. An 
example would be the initiation of a 
new ambulatory clinic with pharmacists 
participating on a medical team. Cali­
fornia residents are required to present 
their projects at the Western States 
Residency Conference (www.western- 
states-rx.org) which is held annually in 
May. At the conference, hospitals and 
clinics with residency programs have 
the opportunity to identify “talent” in 
specialized or general clinical areas.
California has always been a leading 
state in providing residency-trained 
pharmacists. In 2014, California had 
approximately 1 2 1  accredited PGY1 
programs and 33 accredited PGY2 
programs. PGY2 specialty areas include 
administration, ambulatory care, 
cardiology, critical care, drug informa­
tion, emergency medicine, infectious 
diseases, oncology, pain management 
and palliative care, pediatrics, pharmacy 
informatics, psychiatry and solid organ 
transplantation (data provided by ASHP, 
2014). Many residency programs—PGY1 
programs in particular—support more 
than one resident.17 The University of 
Southern California, for example, has 4 
PGY1 and 2 PGY2 residency programs 
with over 40 residents annually. For 
the 2013-14 year (July 1 to June 30), 
there were about 314 pharmacists who 
completed either PGY1 or PGY2 resi­
dencies in California (data provided by 
the California Society of Health-System 
Pharmacists, 2014). Anecdotally, we 
observe that the majority of California- 
trained pharmacists seek to remain in 
California to practice.
L e g is la t iv e  Issu es
As is often the case, the changes in 
practice preceded changes in the law to 
allow them to happen. This is not to say 
that these pharmacists were operating
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outside of the law; only that the law was 
silent on the matter because the existing 
laws were developed before anyone had 
envisioned such services. The California 
legislature recognized this and promul­
gated legislation to keep up with the 
changing environment.
In California, a pharmacist in a medical 
clinic who has successfully completed 
clinical residency training or demon­
strated clinical experience in direct 
patient care delivery has been able to 
legally adjust a patient’s drug regimen 
per clinic approved protocol since 1996 
(AB 2802 Granlund).18 In 1999, the law 
was expanded such that a pharmacist 
could adjust a patient’s drug regimen 
pursuant to a protocol as part of the 
care of a single physician (not neces­
sarily restricted to a clinic setting) (AB 
261 Lempert).19 In 2001, that scope was 
expanded to include initiating a drug 
regimen, not restricted to adjusting a 
drug regimen that had already been 
commenced (AB 826 Cohn).20 In 2006, 
the section of the Business & Profes­
sions Code identifying this scope for 
a pharmacist in a clinic setting was 
renumbered to B&P §4052.2 (AB 2408 
Negrete-McLeod).21
Examining the requirements for the 
application of B&P §4052.2 dealing with 
a pharmacist’s scope of practice in a 
clinic setting, all of the procedures logi­
cally involve patients on drug therapy or 
who will receive drug therapy. Specifi­
cally, a pharmacist may assess the drug 
therapy, including ordering laboratory 
tests, administer drugs and biologicals, 
and initiate and adjust drug regimens 
pursuant to an approved protocol. The 
protocol must be developed by a multi­
disciplinary team that includes both 
physicians and direct care registered 
nurses, who shall determine the breadth 
and limitations of such protocol. The 
protocol must require that the patient 
must first have been seen by a physi­
cian before referral to a pharmacist, and
that the scope of procedures performed 
by the pharmacist must relate to the 
condition for which the patient was first 
seen by the physician. The protocol shall 
require that the patient’s medical record 
be accessible to both the pharmacist 
and the physician, and that any change, 
adjustment, or modification of an 
approved pre-existing treatment or drug 
therapy be provided in writing to the 
treating or supervising physician within 
24 hours.
In order for a pharmacist to be quali­
fied to perform these functions in a 
clinic setting under B&P §4052.2, the 
pharmacist must have either success­
fully completed a clinical residency 
training program, or have demonstrated 
clinical experience in direct patient care 
delivery. Many of the pharmacists who 
have worked in an acute care setting in 
California have this clinical experience 
through the protocols of the hospital 
in managing the dosing of various 
antibiotics, parenteral nutrition, and anti­
coagulation therapies as described above.
In 2013, SB 493 (Hernandez) was 
approved by the California legislature to 
expand the scope of every pharmacist in 
California to furnish hormonal-based 
contraceptives, emergency contracep­
tion, travel medications for international 
travel, immunizations on the Centers 
for Disease Control (CDC)-recom- 
mended schedule, and nicotine-based 
smoking cessation aids, pursuant to 
state approved protocols and subject 
to specified training.22 In addition, the 
bill created a new category of licensed 
pharmacist known as an Advance 
Practice Pharmacist (APP), who would 
not necessarily be restricted to practice 
within a hospital or clinic. In order to 
qualify for licensure as an Advanced 
Practice Pharmacist, the pharmacist 
must have completed two of the three 
following criteria:
continued on page 25
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4210(a) (2) (A): Earn board
certification,
4210(a) (2) (B): Complete a post-grad­
uate clinical residency, and/or
4210(a) (2) (C): Have at least one year
of experience practicing as a clinical
pharmacist.
Under current law, there is no 
requirement for a pharmacist working 
in a clinic under B&P 4052.1 or 
4052.2 to be licensed as an Advanced 
Practice Pharmacist.
To date, the proliferation of clinical 
pharmacists in the ambulatory care 
(clinic) setting has occurred largely in 
managed care organizations such as 
Kaiser Permanente and the Veterans 
Administration, since fee-for-service 
reimbursement is not an issue in these 
environments. A limiting factor outside 
managed care is that pharmacists are 
not yet recognized as providers under 
Medicare Part B for reimbursement, so 
services rendered by pharmacists in the 
clinic are not reimbursable under Medi­
care. HR 4190 was introduced into the 
House of Representatives in Washington, 
DC in March 2014 by Representatives 
Bret Guthrie (R-Ky), G.K. Butterfield 
(D-N.C.), and Todd Young (R-Ind), a 
bill to amend the Social Security Act to 
provide for coverage under the Medi­
care program of pharmacist clinical 
services.23 This bill would have allowed 
pharmacists in the clinics to bill for 
their services through Medicare Part B.
A recent letter from the Administrator 
of CMS affirming that incident-to Part 
B Medicare billing by physicians for 
pharmacist-provided services is lawful 
under specified conditions suggests the 
CMS would not be opposed to such 
legislation.24 Unfortunately, the term of 
the 113th Congress ended before the 
bill could be passed. Now that a new 
session of Congress is underway, bills 
have been introduced on both sides of 
Congress to allow pharmacists to bill for 
services under Medicare Part B in the
Senate under S 31425 and in the House of 
Representatives under HR 59226. This is 
encouraging since bills have been intro­
duced in both the Senate and the House 
of Representatives, and both appear to 
have bipartisan support.
Implications of Healthcare Law 
Changes for Hospitals
Healthcare law changes in 2013-2014 
have the potential to trigger changes in 
affordable care and spur development 
of models that allow hospitals to utilize 
staff more efficiently. Furthermore, 
forecasts for meeting the demand for 
primary care predict that primary care 
physician shortages will increase dramat­
ically by 2025, and there is growing 
evidence that primary care shortages are 
shifting the debate on expanding scope- 
of-practice laws.27 Given the current 
mismatch with patient needs, emergency 
room use for primary care problems is 
on the rise in several regions, and health 
care leaders in those markets believe 
that is due to a shortage of primary 
care physicians. The use of emergency 
departments by Medicaid patients for 
primary care services is a problem for 
insurers who cover that population, 
but it’s also an indication of what may 
be ahead for privately insured patients, 
who cannot get timely appointments 
with primary care providers. Hospitals 
in California are typically located where 
people are located. The geographic 
distribution indicates that hospitals 
are primarily distributed in proportion 
to the number of people, rather than 
income. However, a recent analysis of 
hospitals by population income in LA 
County suggests that people who have 
the least amount of money, may have 
relatively easy geographic access to 
hospitals but limited access to primary 
care.28 Low income areas in California 
may be surrounded by hospitals, but lack 
primary care resources.
How pharmacists get reimbursed 
directly affects the workforce and scope
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of practice. Payment policies have an 
immediate effect that produces change 
in the volume and type of care delivered. 
Historically, health plans have been slow 
to change the way they reimburse for 
care. Increasingly, there is an impetus 
to find reimbursement and workforce 
mechanisms to prevent a diabetic from 
requiring an amputation, rather than a 
reimbursement schema that rewards an 
orthopedic surgeon for the amputation. 
In the absence of creating new efficien­
cies to address physician shortages, 
systemically, we could inadvertently 
develop greater inefficiencies, such as 
increases in emergency department 
use, longer waiting times for appoint­
ments, higher costs for imaging services 
and pharmaceuticals, and utilization 
of specialty care lacking coordination, 
magnified by health reform driven 
improved access to and demand for 
needed health care.
H ea lth  Care R eform  & Physician  
S hortages  in C alifo rn ia
The shortages in primary care physicians 
are evident when mapped and indicate 
that these short falls are a geographic 
issue. Only 16 out of 56 California 
counties have enough primary care 
physicians.29 Effectively, when applied 
to the resident population of the state, 
less than one third of Californians live 
in a place where access to primary 
care physicians meets the needs of the 
population.30 With increased demand 
for health care services and a shortage of 
physicians, the potential gaps in direct 
patient care are likely to widen unless 
alternatives are brought into play.
In California a “Bridging the Provider 
Gap” campaign was initiated through 
the coalition Californians for Acces­
sible Healthcare (comprised of the 
California Association for Health 
System Pharmacists, the California 
Society of Health System Pharmacists, 
the California Optometric Association,
and the California Pharmacists Asso­
ciation). Effects of changes in health 
system management hold the promise 
of achieving efficiencies in staffing and 
producing improvements in outcomes.
Almost 20 percent of Americans, 56 
million people, have inadequate or 
no access to primary care physicians 
because of a shortage of providers, and a 
majority of them are insured, according 
to a report issued by the National 
Association of Community Health 
Centers and the American Academy 
of Family Physicians.31 Multiple 2014 
studies and surveys indicate that the 
number of uninsured fell as a result of 
expanded Medicaid eligibility and health 
insurance exchanges established through 
PPACA. Overall, RAND’s Health Reform 
Opinion Study (HROS) in March 2014 
estimated that 9.3 million more people 
had health care coverage. The increase 
was driven by enrollment in health 
insurance marketplace plans and by 
increases in employer-sponsored insur­
ance and Medicaid enrollment increases. 
Data from August 2014 showed that 7.3 
million people had enrolled through the 
marketplace and paid their premiums.32
B ehind th e  Physician S hortages
The U.S., relative to other countries, 
has low physician to population ratios. 
The physician workforce is aging. The 
population is aging and doctor visits 
increase substantially for those over 65. 
Equally important, the supply of new 
primary care physicians is not sufficient. 
Estimates are that new U.S. educated 
physicians account for an increase each 
year of about 1 percent of the current 
primary care physician workforce.
First year MD enrollment in relation to 
100,000 population has been in steady 
decline since 1980. Limited residency 
slots are a contributing factor. “In 1997, 
the federal government essentially froze 
spending on residency slots, limiting 
the number to around 100,000 over
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three-to-four years, and in turn 
freezing the number of newly licensed 
physicians available for hire each 
year to around 26,000.” While some 
increases have resulted from hospitals 
that have established new residency 
programs for primary care doctors, 
the volume is not sufficient, espe­
cially given the estimated 50 million 
person increase in the U.S. popula­
tion during that time period. “The 
American Association of Medical 
Colleges estimates that the U.S. will 
face a shortage of 46,000 primary care 
doctors by 2020, equivalent to one- 
quarter of everyone practicing in that 
category today.”33
W orkfo rce  and  
C ap acity  Issues
Around 2006, the concept of a U.S. 
shortage of primary care physi­
cians was first publicized.34 Roles 
for advanced practice nurses and 
physician assistants were emphasized 
to “fill the gap”. Given the abun­
dant research (see the Report to the 
Surgeon General) that has shown the 
value of pharmacists in ambulatory 
and primary care activities—both 
from an economical and from an 
outcomes perspective, pharmacists 
can contribute to “filling the gap” 
created by the primary care physician 
shortage.
With approximately 35,000 licensed 
pharmacists in California about 
25% of whom practice in hospitals 
and of those who are hospital-based 
less than half qualifying as clinical 
pharmacists, there are less than 4,500 
clinical pharmacists available for 
implem enting or augmenting clinical 
services in hospital or clinics in Cali­
fornia today.
Nationally, hospital-based pharma­
cists accounted for about 25% of total 
pharmacy positions. Some of these 
pharmacists typically have completed
one or more years of pharmacy 
residency training which is focused 
on higher levels of clinical skills and 
experiences. Some hospitals separate 
clinical pharmacists based on their 
training and role from the rest of the 
pharmacy staff while other hospi­
tals find it more practicable to have 
pharmacists able to perform both 
traditional and newer clinical roles.
M o v in g  Forw ard
Pharmacists are currently able to 
legally function as mid-level prac­
titioners in an ambulatory care 
setting under approved protocols so 
long as they have either (1) success­
fully completed a clinical residency 
training program, or (2) have demon­
strated clinical experience in direct 
patient care delivery. Hospitals and 
health systems looking to insert clin­
ical pharmacists into a medical clinic 
setting may draw from their internal 
resources as well as recruiting new 
pharmacists with hospital experience, 
taking those pharmacists who have 
been functioning in the acute care 
setting practicing direct patient care 
delivery to those hospitalized patients 
and providing them with the opportu­
nity to practice in the ambulatory care 
venue (the attraction of a Monday 
through Friday stable work schedule 
may be appealing). Even though the 
number of pharmacy residencies is 
increasing, only about half of those 
pharmacists who apply actually get 
accepted. One strategy to consider 
is for hospitals to develop their own 
pharmacy residencies with rotations 
in the clinic. Using this strategy, the 
facility gets a pharmacist (usually 
licensed within 90 days of starting) 
to train in both the hospital and the 
clinic for less than half of what it 
costs for a clinical pharmacist for a 
year, and the opportunity to recruit 
the resident when they complete the 
one year program. The proliferation
of the use of pharmacists practicing 
in the ambulatory care environment 
has been hindered by the inability 
to capture reimbursement for these 
services; however the Affordable 
Care Act (ACA) is presenting some 
opportunities allowing pharma­
cists to qualify for “incident-to” 
billing just as much as other clinical 
team members, so long as such 
services are permitted under their 
state license and that “medication 
management services” (billing codes 
99605-99607) are not covered under 
Medicares Part B program, but are 
instead billable under Medicare 
Advantage or Part D medication 
plan.35 Another development is 
HR 4190 introduced in Congress 
earlier this year, which would allow 
pharmacists in the clinics to bill for 
their services through Medicare Part 
B. This bill has bipartisan support 
and is currently being heard in 
committee in the House of Repre­
sentatives in Washington, DC. Given 
the current physician shortage, it 
would make sense to expand the 
use of pharmacists in primary care 
clinics as mid-level providers to 
manage chronic diseases such as 
diabetes, hypertension, hyperlipid­
emia, and other diseases managed 
primarily with medications. O
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